Literature DB >> 21584060

Treatment of acute and transient psychotic disorders with low and high doses of oral haloperidol.

A Khanna1, N Lal, P K Dalal, A Khalid, J K Trivedi.   

Abstract

The apparent rationale for the popular use of high doses of neuroleptics in psychotic patients is to increase the degree and speed of therapeutic response .However, several recent reports have questioned these claims. The present study was undertaken with the aim to compare the efficacy of high and low oral doses of haloperidol in the treatment of acute and transient psychotic disorders. The sample comprised of forty patients of both sexes diagnosed as acute and transient psychotic disorder who were randomly assigned to high dose (20 mg/day) and low dose (5 mg /day) haloperidol groups with equal number of subjects (n=20) in both groups. Weekly assessment was done on Brief Psychiatric Rating Scale and Haloperidol Side-effects Check List (day 7, 14, 21, 28, 35 & 42). Both groups showed significant improvement in BPRS from baseline scores on all assessments. Comparison of the improvement rate in both study groups revealed no significant difference.

Entities:  

Keywords:  Oral haloperidol; acute and transient psychotic disorders; high dose; low dose

Year:  1997        PMID: 21584060      PMCID: PMC2967098     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  28 in total

1.  HALOPERIDOL IN THE TREATMENT OF 120 PSYCHOTIC PATIENTS.

Authors:  J J DANIK; M GOVERDHAM
Journal:  Am J Psychiatry       Date:  1963-10       Impact factor: 18.112

Review 2.  Guidelines for the dosage of antipsychotic drugs.

Authors:  H Beckmann; G Laux
Journal:  Acta Psychiatr Scand Suppl       Date:  1990

3.  Haloperidol blood levels and clinical effects.

Authors:  J Volavka; T Cooper; P Czobor; I Bitter; M Meisner; E Laska; P Gastanaga; M Krakowski; J C Chou; M Crowner
Journal:  Arch Gen Psychiatry       Date:  1992-05

4.  Use of oral haloperidol following rapid tranquilization of acutely disturbed patients.

Authors:  R G Carter
Journal:  W V Med J       Date:  1978-03

5.  A double-blind comparison of haloperidol with perphenazine in acute psychiatric episodes.

Authors:  C H Fitzgerald
Journal:  Curr Ther Res Clin Exp       Date:  1969-08

Review 6.  Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

Authors:  R J Baldessarini; B M Cohen; M H Teicher
Journal:  Arch Gen Psychiatry       Date:  1988-01

7.  Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.

Authors:  A J Levenson; G B Burnett; J D Nottingham; C E Sermas; J I Thornby
Journal:  Curr Ther Res Clin Exp       Date:  1976-11

8.  Rapid tranquilization: the efficacy of oral concentrate.

Authors:  W R Dubin; H M Waxman; K J Weiss; D Ramchandani; C Tavani-Petrone
Journal:  J Clin Psychiatry       Date:  1985-11       Impact factor: 4.384

9.  Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.

Authors:  R W Reschke
Journal:  Dis Nerv Syst       Date:  1974-03

10.  Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers.

Authors:  T Nishikawa; A Tsuda; M Tanaka; I Koga; Y Uchida
Journal:  Biol Psychiatry       Date:  1985-11       Impact factor: 13.382

View more
  2 in total

Review 1.  Acute and Transient Psychotic Disorders: Newer Understanding.

Authors:  Savita Malhotra; Swapnajeet Sahoo; Srinivas Balachander
Journal:  Curr Psychiatry Rep       Date:  2019-11-04       Impact factor: 5.285

2.  The predictive validity and outcome of ICD-10 and DSM-5 short-lived psychotic disorders: a review and meta-analysis.

Authors:  Augusto Castagnini; Leslie Foldager; Ernesto Caffo; German E Berrios
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-06       Impact factor: 5.760

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.